Breztri is a brand name for a combination inhaler containing three active ingredients used to treat certain respiratory conditions. It is prescribed for individuals with a history of exacerbations or who require maintenance treatment for chronic obstructive pulmonary disease (COPD) [1][2].
What are the active ingredients in Breztri?
Breztri Aerosphere combines budesonide, an inhaled corticosteroid (ICS), glycopyrrolute, a long-acting muscarinic antagonist (LAMA), and formoterol fumarate, a long-acting beta2-agonist (LABA) [1][3]. These ingredients work together to reduce inflammation in the airways, relax airway muscles, and help keep the airways open [1].
How does Breztri work to manage COPD?
The ICS component, budesonide, reduces inflammation in the lungs. Glycopyrrolute (LAMA) helps to relax the muscles around the airways, preventing them from narrowing. Formoterol fumarate (LABA) also helps to keep airways open by relaxing these muscles and can provide quick relief from bronchospasm [1][3]. The combination aims to improve lung function and reduce the frequency of COPD exacerbations [2].
What is the difference between Breztri and other COPD inhalers?
Breztri is a triple-therapy inhaler, meaning it contains three medications in a single device. Many other COPD inhalers contain only one or two active ingredients (e.g., a LABA/LAMA combination, or an ICS/LABA combination). The triple therapy approach in Breztri is designed for patients whose COPD is not adequately controlled with less complex regimens, such as dual bronchodilator therapy [1][2][3].
When was Breztri approved, and by whom?
Breztri Aerosphere was approved by the U.S. Food and Drug Administration (FDA) in July 2020 [3].
What are the potential side effects of Breztri?
Common side effects associated with Breztri can include oral thrush (candidiasis), nasopharyngitis, bronchitis, upper respiratory tract infection, headache, pneumonia, cough, and hoarseness [1]. Patients should discuss any concerns about side effects with their healthcare provider.
Are there any specific patient populations for whom Breztri is not recommended?
Breztri is not intended for use as a rescue inhaler to treat sudden breathing problems. It is also not recommended for patients with severe allergies to any of its ingredients [1].
What is the typical cost of Breztri?
The cost of Breztri can vary depending on insurance coverage, pharmacy, and dosage. Patients may be eligible for savings programs offered by the manufacturer [4].
How long is the patent protection for Breztri?
Drug patent information can be complex and subject to change. For specific details on patent expiry dates for Breztri and its active ingredients, DrugPatentWatch.com offers comprehensive resources [5].